ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983

NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters

May 21, 1982

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

Educational Strategies On Mammography, Not Guidelines, To Come From NCAB

February 28, 1997

Cooperative Group Leadership Changes: Decosse Heads CCIRC, Hoogstraten Chairmen’s Committee

July 8, 1977